Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avanafil in Egyptian Males With Erectile and Endothelial Dysfunction
NCT04374994Phase 4Completed
- Sponsor
- Alexandria University
- Start
- Sep 2018
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of avanafil in erectile dysfunction (ED) and endothelial dysfunction (2 arms), sponsored by Alexandria University. Primary endpoints: Nitric Oxide serum level at 4 weeks, Cyclic Guanosine Monophosphate serum level at 4 weeks and 1 more. Started Sep 2018; status: completed.
02
Drugs
avanafil
03
Conditions
erectile dysfunction (ED)endothelial dysfunction
Beyond the preview
Go deeper on NCT04374994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04374994.